Fresenius SE & Co. KGaA Cash & Equivalents Growth & History (FRE)
Fresenius SE & Co. KGaA's cash and equivalents was €1.58B for fiscal 2025.
View full Fresenius SE & Co. KGaA company overviewFresenius SE & Co. KGaA annual cash and equivalents history
| Fiscal year | Period ended | Cash and equivalents | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €1.58B | −€697.0M | −30.54% |
| 2024 | 2024-12-31 | €2.28B | −€280.0M | −10.93% |
| 2023 | 2023-12-31 | €2.56B | −€187.0M | −6.80% |
| 2022 | 2022-12-31 | €2.75B | −€15.0M | −0.54% |
| 2021 | 2021-12-31 | €2.76B | €927.0M | +50.46% |
| 2020 | 2020-12-31 | €1.84B | — | — |
Fresenius SE & Co. KGaA quarterly cash and equivalents
| Fiscal quarter | Period ended | Cash and equivalents | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €1.28B | €53.0M | +4.32% |
| Q1 2026 | 2026-03-31 | €2.06B | −€328.0M | −13.74% |
| Q4 2025 | 2025-12-31 | €1.31B | — | — |
| Q2 2025 | 2025-06-30 | €1.23B | — | — |
| Q1 2025 | 2025-03-31 | €2.39B | — | — |
Fresenius SE & Co. KGaA cash and equivalents trends
Over the last five fiscal years, Fresenius SE & Co. KGaA's cash and equivalents decreased from €1.84B to €1.58B, a change of −€252.0M. The latest reported quarter, Q2 2026, shows €1.28B.
What cash and equivalents mean
Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.
Reported cash and equivalents
TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Fresenius SE & Co. KGaA source filings ↗